4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-003484
Chief Executive Officer sold 28,700 shares at an average $21.39 ($613,843)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…